313 related articles for article (PubMed ID: 12056919)
21. Is hypercholesterolemia a risk factor for Alzheimer's disease?
Wood WG; Igbavboa U; Eckert GP; Johnson-Anuna LN; Müller WE
Mol Neurobiol; 2005; 31(1-3):185-92. PubMed ID: 15953820
[TBL] [Abstract][Full Text] [Related]
22. [Alzheimer's disease and treatment of vascular risk factors].
de Leeuw FE; van Norden AG; van der Flier WM; Olde Rikkert MG; Scheltens P
Ned Tijdschr Geneeskd; 2005 Dec; 149(51):2844-9. PubMed ID: 16398165
[TBL] [Abstract][Full Text] [Related]
23. Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study.
Borghi C; Dormi A; Veronesi M; Sangiorgi Z; Gaddi A;
Am Heart J; 2004 Aug; 148(2):285-92. PubMed ID: 15308998
[TBL] [Abstract][Full Text] [Related]
24. Antihypertensive Agents and Incident Alzheimer's Disease: A Systematic Review and Meta-Analysis of Observational Studies.
Adesuyan M; Jani YH; Alsugeir D; Cheung ECL; Chui CSL; Howard R; Wong ICK; Brauer R
J Prev Alzheimers Dis; 2022; 9(4):715-724. PubMed ID: 36281676
[TBL] [Abstract][Full Text] [Related]
25. Report on statins and dementia disputed.
Muldoon MF
Arch Neurol; 2001 Jul; 58(7):1166-7. PubMed ID: 11448312
[No Abstract] [Full Text] [Related]
26. The new cardiovascular disease prevention guidelines: what you need to know.
Campos-Outcalt D
J Fam Pract; 2014 Feb; 63(2):89-93. PubMed ID: 24527471
[No Abstract] [Full Text] [Related]
27. Update on hypertension and Alzheimer's disease.
Skoog I; Gustafson D
Neurol Res; 2006 Sep; 28(6):605-11. PubMed ID: 16945211
[TBL] [Abstract][Full Text] [Related]
28. Cholesterol levels in untreated Spanish hypertensive patients. The Compas Study Group, Spanish Hypertension Society.
Aranda P; Rodicio JL; Luque M; Banegas JR; Barajas R; Aranda FJ; Sobrino P
Blood Press; 1999; 8(5-6):273-8. PubMed ID: 10803487
[TBL] [Abstract][Full Text] [Related]
29. [Prevention of cardiovascular complications after a stroke or TIA: hypotensive and hypocholesterolemic therapy].
Dippel DW; van der Worp HB
Ned Tijdschr Geneeskd; 2004 Apr; 148(17):820-4. PubMed ID: 15141647
[TBL] [Abstract][Full Text] [Related]
30. [Dynamics of prevalence of arterial hypertension and other risk factors of development of cardiovascular diseases in female population of Tallin (10 year prospective study)].
Shipilova T; Pshenichnikov I; Abina E; Karaĭ D; Ripul'k E; Veski K; Pil't K; Meĭgas K; Kaĭk Iu
Kardiologiia; 2010; 50(11):40-6. PubMed ID: 21526563
[TBL] [Abstract][Full Text] [Related]
31. [Epidemiology of Alzheimer's disease].
Dufouil C; Alpérovitch A
Rev Prat; 2005 Nov; 55(17):1869-78. PubMed ID: 16396227
[TBL] [Abstract][Full Text] [Related]
32. [Type 2 diabetes and cardiovascular risk: lessons from therapeutic trials].
Lièvre M
Rev Prat; 2001 Oct; 51(16):1793-9. PubMed ID: 11795124
[TBL] [Abstract][Full Text] [Related]
33. Guidelines and reported practice for the treatment of hypertension and hypercholesterolaemia.
Troein M; Gardell B; Selander S; Råstam L
J Intern Med; 1997 Aug; 242(2):173-8. PubMed ID: 9279295
[TBL] [Abstract][Full Text] [Related]
34. Undertreatment of hypertension and hypercholesterolaemia in children and adolescents with type 1 diabetes: long-term follow-up on time trends in the occurrence of cardiovascular disease, risk factors and medications use.
Ahmadizar F; Souverein P; de Boer A; Maitland-van der Zee AH
Br J Clin Pharmacol; 2018 Apr; 84(4):776-785. PubMed ID: 29218780
[TBL] [Abstract][Full Text] [Related]
35. Hypertension and dementia.
Nagai M; Hoshide S; Kario K
Am J Hypertens; 2010 Feb; 23(2):116-24. PubMed ID: 19927134
[TBL] [Abstract][Full Text] [Related]
36. Lipid-lowering therapy and risk of coronary events.
Lardinois CK
JAMA; 2003 Apr 23-30; 289(16):2071; author reply 2071-2. PubMed ID: 12709463
[No Abstract] [Full Text] [Related]
37. [Vascular risk factors and Alzheimer disease risk: epidemiological studies review].
Cowppli-Bony P; Dartigues JF; Orgogozo JM
Psychol Neuropsychiatr Vieil; 2006 Mar; 4(1):47-60. PubMed ID: 16556518
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of ETC-1002, a novel investigational low-density lipoprotein-cholesterol-lowering therapy for the treatment of patients with hypercholesterolemia and type 2 diabetes mellitus.
Gutierrez MJ; Rosenberg NL; Macdougall DE; Hanselman JC; Margulies JR; Strange P; Milad MA; McBride SJ; Newton RS
Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):676-83. PubMed ID: 24385236
[TBL] [Abstract][Full Text] [Related]
39. Use of antihypertensive and lipid-lowering drugs: the management of cardiovascular risk in clinical practice.
Di Martino M; Degli Esposti L; Filigheddu F; Veronesi C; Salerno G; Saragoni S; Glorioso N; Didoni G; Degli Esposti E
J Hum Hypertens; 2007 Jan; 21(1):53-9. PubMed ID: 17036042
[TBL] [Abstract][Full Text] [Related]
40. Modification of hypertension and hypercholesterolaemia in patients with systemic lupus erythematosus: a quality improvement study.
Urowitz MB; Gladman DD; Ibanez D; Berliner Y
Ann Rheum Dis; 2006 Jan; 65(1):115-7. PubMed ID: 16344496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
